Mesoblast Limited revenue breakdown overview

Mesoblast Limited revenue for the last year amounted to 7.50 M USD, the most of which — 7.50 M USD — came from its highest performing source at the moment, Adult Stem Cell Technology, the year earlier bringing 10.21 M USD. The greatest contribution to the revenue figure was made by Australia, United States and Singapore — last year it brought Mesoblast Limited 7.50 M USD, and the year before that — 10.21 M USD.